Screening high‐risk populations for colon and rectal cancers
Authors:
- 31 July 2019
- journal article
- review article
- Published by Wiley in Journal of Surgical Oncology
- Vol. 120 (5) , 858-863
Abstract
Currently, colorectal cancers accounted for the second‐highest number of cancer deaths in the US. Hereditary syndromes, strong family history, and inflammatory bowel disease are all conditions that confer predisposition risks. In hereditary syndromes, screening must be more frequent and start earlier. With familial risk, screening should depend on the age of cancer onset and number of affected relatives. For inflammatory bowel disease, surveillance should depend on duration, severity, and extent of colitis.Keywords
This publication has 59 references indexed in Scilit:
- Cancer Risks forMLH1andMSH2Mutation CarriersHuman Mutation, 2013
- Socioeconomic status and the risk of colorectal cancerCancer, 2012
- Cancer Risks Associated With Germline Mutations in MLH1, MSH2, and MSH6 Genes in Lynch SyndromeJAMA, 2011
- Colonoscopic findings in first-degree relatives of patients with colorectal cancer: a population-based screening programGastrointestinal Endoscopy, 2011
- Risks of Lynch Syndrome Cancers for MSH6 Mutation CarriersJNCI: Journal of the National Cancer Institute, 2010
- The Clinical Phenotype of Lynch Syndrome Due to Germ-Line PMS2 MutationsGastroenterology, 2008
- Epidemiology and Risk Factors for Colorectal Dysplasia and Cancer in Ulcerative ColitisGastroenterology Clinics of North America, 2006
- Relative and absolute risk of colorectal cancer for individuals with a family history: A meta-analysisEuropean Journal of Cancer, 2006
- Colorectal cancer screening and surveillance: Clinical guidelines and rationale?Update based on new evidenceGastroenterology, 2003
- Increased risk of large-bowel cancer in Crohn's disease with colonic involvementThe Lancet, 1990